Nordic Lymphoma Group

Recent papers from Nordic Lymphoma Group

1. p38γ and p38δ support CD4+ T cell responses and T cell-dependent humoral immunityFrontiers in Immunology · 2026
2. Clinical significance of high-density lipoprotein cholesterol and its dynamic change in patients with lymphoma-associated hemophagocytic lymphohistiocytosisTherapeutic Advances in Medical Oncology · 2026
3. Topical hypericin: a promising photodynamic therapy for early-stage cutaneous T-cell lymphomaExpert Opinion on Investigational Drugs · 2026
4. Hemophagocytic lymphohistiocytosis associated with extranodal NK/T cell lymphoma, nasal type or aggressive NK cell leukemia: a retrospective multicenter study of Jiangsu Cooperative Lymphoma Group (JCLG)SHILAP Revista de lepidopterología · 2026
5. The impact of time‐to‐recurrence on post‐recurrence mortality in stage I– III colorectal cancer: A nationwide Danish cohort studyInternational Journal of Cancer · 2026
6. Preoperative positive ctDNA analysis is associated with the tumor microenvironment, and the risk of recurrence in non-metastatic colorectal cancernpj Precision Oncology · 2026
7. Days alive and out of hospital at 90 days as a composite outcome measure in patients undergoing elective surgery for colorectal cancer– a nationwide, observational studyBMC Gastroenterology · 2025
8. Minimizing Post-Operative Scars in External Dacryocystorhinostomy: A Literature ReviewClinical ophthalmology · 2025
9. Estimating the potential economic and health impact of integrated genomic surveillance in a hospital settingClinical Microbiology and Infection · 2025
10. Clinical implementation of an AI-based prediction model for decision support for patients undergoing colorectal cancer surgeryNature Medicine · 2025
11. Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced‐stage Hodgkin lymphoma in older patientsHemaSphere · 2025
12. Positron Emission Tomography–Guided Brentuximab Vedotin, Etoposide, Cyclophosphamide, Doxorubicin, Dacarbazine, and Dexamethasone in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma: A Prospective, Multicenter, Single-Arm, Phase II Cohort of the German Hodgkin Study Group HD21 TrialJournal of Clinical Oncology · 2025
13. Timing of ctDNA Analysis Aimed at Guiding Adjuvant Treatment in Colorectal CancerClinical Cancer Research · 2025
14. Targeting LMO2-induced autocrine FLT3 signaling to overcome chemoresistance in early T-cell precursor acute lymphoblastic leukemiaLeukemia · 2025
15. Pre-phase treatment with rituximab and high-dose methotrexate to re-evaluate eligibility for intensive induction treatment of frail patients with central nervous system lymphomaHaematologica · 2025
16. Associations between pre-operative cholesterol levels with long-term survival after colorectal cancer surgery: a nationwide propensity score–matched cohort studyInternational Journal of Colorectal Disease · 2024
17. Risk of recurrence in early-onset versus late-onset non-metastatic colorectal cancer, 2004–2019: a nationwide cohort studyThe Lancet Regional Health - Europe · 2024
18. Time From Colorectal Cancer Surgery to Adjuvant ChemotherapyJAMA Surgery · 2024
19. Correlations between preoperative statin treatment with short- and long-term survival following colorectal cancer surgery: a propensity score-matched national cohort studyInternational Journal of Colorectal Disease · 2024
20. Cardiovascular events after elective colorectal cancer surgery in patients with stage I-III disease with no previous cardiovascular diseaseActa Oncologica · 2023